118 related articles for article (PubMed ID: 38417630)
1. Global Interactome Mapping Reveals Pro-tumorigenic Interactions of NF-κB in Breast Cancer.
Lapcik P; Stacey RG; Potesil D; Kulhanek P; Foster LJ; Bouchal P
Mol Cell Proteomics; 2024 Apr; 23(4):100744. PubMed ID: 38417630
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid protects human breast cancer cells against etoposide-induced apoptosis by NF-kappaB-dependent but cIAP2-independent mechanisms.
Jiménez-Lara AM; Aranda A; Gronemeyer H
Mol Cancer; 2010 Jan; 9():15. PubMed ID: 20102612
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways.
Keklikoglou I; Koerner C; Schmidt C; Zhang JD; Heckmann D; Shavinskaya A; Allgayer H; Gückel B; Fehm T; Schneeweiss A; Sahin O; Wiemann S; Tschulena U
Oncogene; 2012 Sep; 31(37):4150-63. PubMed ID: 22158050
[TBL] [Abstract][Full Text] [Related]
4. Asymmetric arginine dimethylation of RelA provides a repressive mark to modulate TNFα/NF-κB response.
Reintjes A; Fuchs JE; Kremser L; Lindner HH; Liedl KR; Huber LA; Valovka T
Proc Natl Acad Sci U S A; 2016 Apr; 113(16):4326-31. PubMed ID: 27051065
[TBL] [Abstract][Full Text] [Related]
5. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
[TBL] [Abstract][Full Text] [Related]
6. Trastuzumab-Resistant Luminal B Breast Cancer Cells Show Basal-Like Cell Growth Features Through NF-κB-Activation.
Kanzaki H; Mukhopadhya NK; Cui X; Ramanujan VK; Murali R
Monoclon Antib Immunodiagn Immunother; 2016 Feb; 35(1):1-11. PubMed ID: 26871511
[TBL] [Abstract][Full Text] [Related]
7. PRMT5 dimethylates R30 of the p65 subunit to activate NF-κB.
Wei H; Wang B; Miyagi M; She Y; Gopalan B; Huang DB; Ghosh G; Stark GR; Lu T
Proc Natl Acad Sci U S A; 2013 Aug; 110(33):13516-21. PubMed ID: 23904475
[TBL] [Abstract][Full Text] [Related]
8. Negative regulation of NF-κB by the ING4 tumor suppressor in breast cancer.
Byron SA; Min E; Thal TS; Hostetter G; Watanabe AT; Azorsa DO; Little TH; Tapia C; Kim S
PLoS One; 2012; 7(10):e46823. PubMed ID: 23056468
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
[TBL] [Abstract][Full Text] [Related]
10. Regulation of anoikis by deleted in breast cancer-1 (DBC1) through NF-κB.
Park SH; Riley P; Frisch SM
Apoptosis; 2013 Aug; 18(8):949-62. PubMed ID: 23588592
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the RelA:CBP/p300 interaction reveals its involvement in NF-κB-driven transcription.
Mukherjee SP; Behar M; Birnbaum HA; Hoffmann A; Wright PE; Ghosh G
PLoS Biol; 2013 Sep; 11(9):e1001647. PubMed ID: 24019758
[TBL] [Abstract][Full Text] [Related]
12. Quantification of activated NF-kappaB/RelA complexes using ssDNA aptamer affinity-stable isotope dilution-selected reaction monitoring-mass spectrometry.
Zhao Y; Widen SG; Jamaluddin M; Tian B; Wood TG; Edeh CB; Brasier AR
Mol Cell Proteomics; 2011 Jun; 10(6):M111.008771. PubMed ID: 21502374
[TBL] [Abstract][Full Text] [Related]
13. RNA helicase p68 deploys β-catenin in regulating RelA/p65 gene expression: implications in colon cancer.
Khare V; Tabassum S; Chatterjee U; Chatterjee S; Ghosh MK
J Exp Clin Cancer Res; 2019 Jul; 38(1):330. PubMed ID: 31351496
[TBL] [Abstract][Full Text] [Related]
14. Golgi tethering factor golgin-97 suppresses breast cancer cell invasiveness by modulating NF-κB activity.
Hsu RM; Zhong CY; Wang CL; Liao WC; Yang C; Lin SY; Lin JW; Cheng HY; Li PY; Yu CJ
Cell Commun Signal; 2018 Apr; 16(1):19. PubMed ID: 29703230
[TBL] [Abstract][Full Text] [Related]
15. BRCA1 augments transcription by the NF-kappaB transcription factor by binding to the Rel domain of the p65/RelA subunit.
Benezra M; Chevallier N; Morrison DJ; MacLachlan TK; El-Deiry WS; Licht JD
J Biol Chem; 2003 Jul; 278(29):26333-41. PubMed ID: 12700228
[TBL] [Abstract][Full Text] [Related]
16. Significance of Tissue Expression and Serum Levels of Angiopoietin-like Protein 4 in Breast Cancer Progression: Link to NF-κB /P65 Activity and Pro-Inflammatory Cytokines.
Shafik NM; Mohamed DA; Bedder AE; El-Gendy AM
Asian Pac J Cancer Prev; 2015; 16(18):8579-87. PubMed ID: 26745120
[TBL] [Abstract][Full Text] [Related]
17. TWIST1 associates with NF-κB subunit RELA via carboxyl-terminal WR domain to promote cell autonomous invasion through IL8 production.
Li S; Kendall SE; Raices R; Finlay J; Covarrubias M; Liu Z; Lowe G; Lin YH; Teh YH; Leigh V; Dhillon S; Flanagan S; Aboody KS; Glackin CA
BMC Biol; 2012 Aug; 10():73. PubMed ID: 22891766
[TBL] [Abstract][Full Text] [Related]
18. LRRC25 Functions as an Inhibitor of NF-κB Signaling Pathway by Promoting p65/RelA for Autophagic Degradation.
Feng Y; Duan T; Du Y; Jin S; Wang M; Cui J; Wang RF
Sci Rep; 2017 Oct; 7(1):13448. PubMed ID: 29044191
[TBL] [Abstract][Full Text] [Related]
19. RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland.
Demicco EG; Kavanagh KT; Romieu-Mourez R; Wang X; Shin SR; Landesman-Bollag E; Seldin DC; Sonenshein GE
Mol Cell Biol; 2005 Nov; 25(22):10136-47. PubMed ID: 16260626
[TBL] [Abstract][Full Text] [Related]
20. Chromatin remodeling protein SMAR1 regulates NF-κB dependent Interleukin-8 transcription in breast cancer.
Malonia SK; Yadav B; Sinha S; Lazennec G; Chattopadhyay S
Int J Biochem Cell Biol; 2014 Oct; 55():220-6. PubMed ID: 25239884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
